GLPG-3312 / Lakefront Biotherapeutics, Gilead - LARVOL DELTA

Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312. (PubMed, J Med Chem) - "Characterization of the first human SIK3 crystal structure provided an understanding of the binding mode and kinome selectivity of the chemical series. GLPG3312 demonstrated both anti-inflammatory and immunoregulatory activities in vitro in human primary myeloid cells and in vivo in mouse models."

Journal • PK/PD data • Inflammation • AMPK • SIK1